Rhea Gandhi
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
Publications
11
Citations
61
Est. group size
~5
Recurring co-author estimate
Active years
9
Publishing since 2018
Rhea Gandhi's publication record spans a mix of clinical research topics, including Parkinson's disease-related psychiatric and cognitive complications, movement disorder treatments, lung cancer screening processes, nephrology journal editorial practices, and drug-resistant tuberculosis treatment side effects. The work is largely clinical and health-services oriented, drawing on patient data, survey methods, and clinical trials rather than laboratory-based molecular biology despite the broad subject classification. This suggests a research focus on clinical outcomes, healthcare systems, and diversity/equity issues within medical publishing alongside neurological disease management.
Publication output was minimal or absent for much of the past decade but has grown steadily since 2022, with the highest activity occurring in 2024-2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Reliability of Electronic Medical Record to Assess Patient’s Eligibility for Lung Cancer Screening: Analysis of Two Pilot Trials
Journal of the American College of Radiology · 2025
- Double-Blind, Randomized, Placebo-Controlled, Crossover Study of Oral Cannabidiol and Tetrahydrocannabinol for Essential Tremor
Tremor and Other Hyperkinetic Movements · 2025
- A Survey Study To Assess the Diversity and Inclusion in Nephrology Journal Editorial Leadership
Clinical Journal of the American Society of Nephrology · 2025
- Assessing Diversity and Inclusion in Nephrology Journal Editorial Leadership: EDI-N Study
Journal of the American Society of Nephrology · 2024
- Cycloserine-induced psychosis in patients with drug-resistant tuberculosis: A case series
Industrial Psychiatry Journal · 2024
- Clinical trials for cognition in Parkinson's disease: Where are we and how can we do better?
Parkinsonism & Related Disorders · 2023
- Mortality in patients with Parkinson disease psychosis receiving pimavanserin and quetiapine
Neurology · 2018
- bioRxiv (Cold Spring Harbor Laboratory)×4
- Neurology×1
- Parkinsonism & Related Disorders×1
- Journal of the American College of Radiology×1
- Journal of the American Society of Nephrology×1
- Yves V. Brun
Biochemistry, Genetics and Molecular Biology · Indiana University
- Gail G. Hardy
Biochemistry, Genetics and Molecular Biology · Indiana University
- Jennifer L. Greenwich
Biochemistry, Genetics and Molecular Biology · Indiana University
- Nicholas D. Christman
Biochemistry, Genetics and Molecular Biology · Indiana University
- Ayushi Mishra
Biochemistry, Genetics and Molecular Biology · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 20, 2026.
Claim or correct this profile